April 2024 | Sinfonie attends the German Biotech Days and the Swiss Biotech Day
This month, Sinfonie took part in two events awaited by the European biotech sphere: the German Biotech Days and the Swiss Biotech Day. These gatherings serve as pivotal platforms for industry professionals to exchange knowledge, foster collaborations, and explore emerging trends in the biotechnology sector.
The German Biotech Days, held on April 8th–9th, provided a platform for Sinfonie to engage with key players in the German biotech industry, fostering collaborations and exchanging insights on the latest advancements in the field.
Following this, Sinfonie participated in the Swiss Biotech Day on April 23rd. Amidst discussions on cutting-edge research, financing trends, and regulatory updates, Sinfonie leveraged this opportunity to network with industry peers and explore potential avenues for strategic partnerships.
With a dedicated focus on BD & Licensing, Strategic Advisory, and M&A transactions, Sinfonie’s presence at these events reaffirms its dedication to driving innovation and facilitating impactful partnerships within the life science community.
March 2024 | Sinfonie will attend BIO-Europe Spring on March 18th–20th in Barcelona
Our Managing Director, Martin Pöhlchen, will be looking to engage with previous and prospective clients, explore collaborative opportunities, and share insights with industry leaders at the upcoming BIO-Europe Spring.
January 2024 | Sinfonie will attend Biotech Showcase on January 8–10 in San Francisco
Sinfonie’s Managing Director Peter Heinrich will attend Biotech Showcase this January. Sinfonie looks forward to catching up with previous clients and collaborators, and to making new connections with Biotech, Pharma and Digital Health companies interested in BD & Licensing, Strategic Advisory and M&A transactions.
November 2023 | Sinfonie will attend BIO-Europe on November 6-8 in Munich
Sinfonie’s Managing Director Martin Pöhlchen will attend BIO-Europe this November, a short way from Sinfonie’s headquarters in Munich. Sinfonie looks forward to connecting with Biotech and Pharma companies to promote existing and prospective projects in BD & Licensing, Strategic Advisory and M&A transactions.
August 2023 | Sinfonie is glad to share that it acted as a strategic co-advisor for PPF Biotech and SCTbio in the transaction with eureKING
PPF to participate in formation of leading new European biotech manufacturer
Sinfonie Life Science Management and Alira Health acted as strategic advisors to SCTbio and PPF Biotech Group in this transaction with eureKing, the first European healthcare SPAC dedicated to biomanufacturing. Please find out more by downloading our press statement below.
July 2023 | We are happy to share that Dr. Liliana Garcia Mondragon has joined Sinfonie as a consultant.
Welcome to the team, Liliana!
January 2023 | We are happy to announce that Dr. Dorothee Pöhlchen has joined Sinfonie as a consultant.
Welcome to the team, Dorothee!